The DOI matches its Crossref record; 126 of the 126 references it cites were found in a registry or an index.
Engineering synthetic vaccines using cues from natural immunity
Open accessAbstract
Vaccines aim to protect against or treat diseases through manipulation of the immune response, promoting either immunity or tolerance. The former generate antibodies and T-cells poised to protect against future pathogen encounter or attack diseased cells such as tumors; the latter, which are far less developed, block pathogenic autoreactive T-cells and autoantibodies that target self tissue. Enormous challenges remain, however, as a consequence of our incomplete understanding of human immunity. A rapidly growing field of research is the design of synthetic materials in vaccines to 1) target organs, tissues, cells, or intracellular compartments; 2) co-deliver immunomodulatory signals that control the quality of the immune response; or 3) directly act as immune regulators, and there exists great potential for well-defined materials to further our understanding of immunity. Here we describe recent advances in the design of synthetic materials to direct immune responses, highlighting successes and challenges in prophylactic, therapeutic, and tolerance-inducing vaccines.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dendritic cells and the control of immunity
Banchereau, J., & Steinman, R. M. (1998) · Nature · doi:10.1038/32588 · Cited by 14,336
Safety, activity, and immune correlates of anti–PD-1 antibody in cancer
Topalian, S. L., Hodi, F. S., Brahmer, J. R., Gettinger, S. N., Smith, D. C., McDermott, D. F., Powderly, J. D., Carvajal, R. D., Sosman, J. A., Atkins, M. B., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1200690 · Cited by 12,628
Safety and activity of anti-PD-L1 antibody in patients with advanced cancer
Brahmer, J. R., Tykodi, S. S., Chow, L. Q. M., Hwu, W.-J., Topalian, S. L., Hwu, P., Drake, C. G., Camacho, L. H., Kauh, J., Odunsi, K., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1200694 · Cited by 7,945
Cancer immunotherapy comes of age
Mellman, I., Coukos, G., & Dranoff, G. (2011) · Nature · doi:10.1038/nature10673 · Cited by 3,893
Hornung, V., Bauernfeind, F., Halle, A., Samstad, E. O., Kono, H., Rock, K. L., Fitzgerald, K. A., & Latz, E. (2008) · Nature Immunology · doi:10.1038/ni.1631 · Cited by 3,065
Taking dendritic cells into medicine
Steinman, R. M., & Banchereau, J. (2007) · Nature · doi:10.1038/nature06175 · Cited by 2,127
Vaccine delivery: a matter of size, geometry, kinetics and molecular patterns
Bachmann, M. F., & Jennings, G. T. (2010) · Nature Reviews Immunology · doi:10.1038/nri2868 · Cited by 2,106
Molecular identification of a danger signal that alerts the immune system to dying cells
Shi, Y., Evans, J. E., & Rock, K. L. (2003) · Nature · doi:10.1038/nature01991 · Cited by 1,684
The roles of TLRs, RLRs and NLRs in pathogen recognition
Kawai, T., & Akira, S. (2009) · International Immunology · doi:10.1093/intimm/dxp017 · Cited by 1,670
Wherry, E. J., Blattman, J. N., Murali-Krishna, K., van der Most, R., & Ahmed, R. (2003) · Journal of Virology · doi:10.1128/jvi.77.8.4911-4927.2003 · Cited by 1,610
Exploiting lymphatic transport and complement activation in nanoparticle vaccines
Reddy, S. T., van der Vlies, A. J., Simeoni, E., Angeli, V., Randolph, G. J., O'Neil, C. P., Lee, L. K., Swartz, M. A., & Hubbell, J. A. (2007) · Nature Biotechnology · doi:10.1038/nbt1332 · Cited by 1,350
Self-citationThe Regulation of Immunity to Leishmania major
Reiner, S. L. (1995) · Annual Review of Immunology · doi:10.1146/annurev.immunol.13.1.151 · Cited by 1,297
Surface-structure-regulated cell-membrane penetration by monolayer-protected nanoparticles
Verma, A., Uzun, O., Hu, Y., Hu, Y., Han, H.-S., Watson, N., Chen, S., Irvine, D. J., & Stellacci, F. (2008) · Nature Materials · doi:10.1038/nmat2202 · Cited by 1,266
Self-citationMucosal vaccines: the promise and the challenge
Neutra, M. R., & Kozlowski, P. A. (2006) · Nature Reviews Immunology · doi:10.1038/nri1777 · Cited by 1,223
Seong, S.-Y., & Matzinger, P. (2004) · Nature Reviews Immunology · doi:10.1038/nri1372 · Cited by 1,220
The adherent gastrointestinal mucus gel layer: thickness and physical state in vivo
Atuma, C., Strugala, V., Allen, A., & Holm, L. (2001) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.2001.280.5.g922 · Cited by 1,078
Rapid transport of large polymeric nanoparticles in fresh undiluted human mucus
Lai, S. K., O'Hanlon, D. E., Harrold, S., Man, S. T., Wang, Y.-Y., Cone, R., & Hanes, J. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0608611104 · Cited by 1,050
Programming the magnitude and persistence of antibody responses with innate immunity
Kasturi, S. P., Skountzou, I., Albrecht, R. A., Koutsonanos, D., Hua, T., Nakaya, H. I., Ravindran, R., Stewart, S., Alam, M., Kwissa, M., et al. (2011) · Nature · doi:10.1038/nature09737 · Cited by 975
Dissolving polymer microneedle patches for influenza vaccination
Sullivan, S. P., Koutsonanos, D. G., del Pilar Martin, M., Lee, J. W., Zarnitsyn, V., Choi, S.-O., Murthy, N., Compans, R. W., Skountzou, I., & Prausnitz, M. R. (2010) · Nature Medicine · doi:10.1038/nm.2182 · Cited by 948
Towards an understanding of the adjuvant action of aluminium
Marrack, P., McKee, A. S., & Munks, M. W. (2009) · Nature Reviews Immunology · doi:10.1038/nri2510 · Cited by 887
A Phagosome-to-Cytosol Pathway for Exogenous Antigens Presented on MHC Class I Molecules
Kovacsovics-Bankowski, M., & Rock, K. L. (1995) · Science · doi:10.1126/science.7809629 · Cited by 884
Toll-dependent selection of microbial antigens for presentation by dendritic cells
Blander, J. M., & Medzhitov, R. (2006) · Nature · doi:10.1038/nature04596 · Cited by 840
Nonviral delivery of self-amplifying RNA vaccines
Geall, A. J., Verma, A., Otten, G. R., Shaw, C. A., Hekele, A., Banerjee, K., Cu, Y., Beard, C. W., Brito, L. A., Krucker, T., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1209367109 · Cited by 741
T-helper-1-cell cytokines drive cancer into senescence
Braumüller, H., Wieder, T., Brenner, E., Aßmann, S., Hahn, M., Alkhaled, M., Schilbach, K., Essmann, F., Kneilling, M., Griessinger, C., et al. (2013) · Nature · doi:10.1038/nature11824 · Cited by 720
Itano, A. A., McSorley, S. J., Reinhardt, R. L., Ehst, B. D., Ingulli, E., Rudensky, A. Y., & Jenkins, M. K. (2003) · Immunity · doi:10.1016/s1074-7613(03)00175-4 · Cited by 718
The Influence of Antigen Organization on B Cell Responsiveness
Bachmann, M. F., Rohrer, U. H., Kündig, T. M., Bürki, K., Hengartner, H., & Zinkernagel, R. M. (1993) · Science · doi:10.1126/science.8248784 · Cited by 717
Size-Dependent Immunogenicity: Therapeutic and Protective Properties of Nano-Vaccines against Tumors
Fifis, T., Gamvrellis, A., Crimeen-Irwin, B., Pietersz, G. A., Li, J., Mottram, P. L., McKenzie, I. F. C., & Plebanski, M. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.5.3148 · Cited by 664
Stabilization of proteins encapsulated in injectable poly (lactide- co-glycolide)
Zhu, G., Mallery, S. R., & Schwendeman, S. P. (2000) · Nature Biotechnology · doi:10.1038/71916 · Cited by 609
Vaccines: past, present and future
Plotkin, S. A. (2005) · Nature Medicine · doi:10.1038/nm1209 · Cited by 592
Moon, J. J., Suh, H., Bershteyn, A., Stephan, M. T., Liu, H., Huang, B., Sohail, M., Luo, S., Ho Um, S., Khant, H., et al. (2011) · Nature Materials · doi:10.1038/nmat2960 · Cited by 564
Self-citationUptake of particulate vaccine adjuvants by dendritic cells activates the NALP3 inflammasome
Sharp, F. A., Ruane, D., Claass, B., Creagh, E., Harris, J., Malyala, P., Singh, M., O'Hagan, D. T., Pétrilli, V., Tschopp, J., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0804897106 · Cited by 540
DNA released from dying host cells mediates aluminum adjuvant activity
Marichal, T., Ohata, K., Bedoret, D., Mesnil, C., Sabatel, C., Kobiyama, K., Lekeux, P., Coban, C., Akira, S., Ishii, K. J., et al. (2011) · Nature Medicine · doi:10.1038/nm.2403 · Cited by 535
Enzyme Encapsulation in Layer-by-Layer Engineered Polymer Multilayer Capsules
Caruso, F., Trau, D., Möhwald, H., & Renneberg, R. (2000) · Langmuir · doi:10.1021/la991161n · Cited by 533
A self-assembling peptide acting as an immune adjuvant
Rudra, J. S., Tian, Y. F., Jung, J. P., & Collier, J. H. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0912124107 · Cited by 523
Nanoparticle Hydrophobicity Dictates Immune Response
Moyano, D. F., Goldsmith, M., Solfiell, D. J., Landesman-Milo, D., Miranda, O. R., Peer, D., & Rotello, V. M. (2012) · Journal of the American Chemical Society · doi:10.1021/ja2108905 · Cited by 478
Nanogel antigenic protein-delivery system for adjuvant-free intranasal vaccines
Nochi, T., Yuki, Y., Takahashi, H., Sawada, S.-I., Mejima, M., Kohda, T., Harada, N., Kong, I. G., Sato, A., Kataoka, N., et al. (2010) · Nature Materials · doi:10.1038/nmat2784 · Cited by 468
Hailemichael, Y., Dai, Z., Jaffarzad, N., Ye, Y., Medina, M. A., Huang, X.-F., Dorta-Estremera, S. M., Greeley, N. R., Nitti, G., Peng, W., et al. (2013) · Nature Medicine · doi:10.1038/nm.3105 · Cited by 457
Biodegradable polymer nanoparticles that rapidly penetrate the human mucus barrier
Tang, B. C., Dawson, M., Lai, S. K., Wang, Y.-Y., Suk, J. S., Yang, M., Zeitlin, P., Boyle, M. P., Fu, J., & Hanes, J. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0905998106 · Cited by 453
Infection-mimicking materials to program dendritic cells in situ
Ali, O. A., Huebsch, N., Cao, L., Dranoff, G., & Mooney, D. J. (2009) · Nature Materials · doi:10.1038/nmat2357 · Cited by 434
Shen, H., Ackerman, A. L., Cody, V., Giodini, A., Hinson, E. R., Cresswell, P., Edelson, R. L., Saltzman, W. M., & Hanlon, D. J. (2006) · Immunology · doi:10.1111/j.1365-2567.2005.02268.x · Cited by 420
High antigen levels are the cause of T cell exhaustion during chronic viral infection
Mueller, S. N., & Ahmed, R. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0809818106 · Cited by 406
Alum interaction with dendritic cell membrane lipids is essential for its adjuvanticity
Flach, T. L., Ng, G., Hari, A., Desrosiers, M. D., Zhang, P., Ward, S. M., Seamone, M. E., Vilaysane, A., Mucsi, A. D., Fong, Y., et al. (2011) · Nature Medicine · doi:10.1038/nm.2306 · Cited by 405
Murthy, N., Xu, M., Schuck, S., Kunisawa, J., Shastri, N., & Fréchet, J. M. J. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0930644100 · Cited by 405
CD8+ T cell efficacy in vaccination and disease
Appay, V., Douek, D. C., & Price, D. A. (2008) · Nature Medicine · doi:10.1038/nm.f.1774 · Cited by 393
Getts, D. R., Martin, A. J., McCarthy, D. P., Terry, R. L., Hunter, Z. N., Yap, W. T., Getts, M. T., Pleiss, M., Luo, X., King, N. J., et al. (2012) · Nature Biotechnology · doi:10.1038/nbt.2434 · Cited by 392
Pape, K. A., Catron, D. M., Itano, A. A., & Jenkins, M. K. (2007) · Immunity · doi:10.1016/j.immuni.2007.02.011 · Cited by 391
Nanoparticles reveal that human cervicovaginal mucus is riddled with pores larger than viruses
Lai, S. K., Wang, Y.-Y., Hida, K., Cone, R., & Hanes, J. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0911748107 · Cited by 384
Pulendran, B., Li, S., & Nakaya, H. I. (2010) · Immunity · doi:10.1016/j.immuni.2010.10.006 · Cited by 380
Mucus-Penetrating Nanoparticles for Vaginal Drug Delivery Protect Against Herpes Simplex Virus
Ensign, L. M., Tang, B. C., Wang, Y.-Y., Tse, T. A., Hoen, T., Cone, R., & Hanes, J. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3003453 · Cited by 368
Li, H., Li, Y., Jiao, J., & Hu, H.-M. (2011) · Nature Nanotechnology · doi:10.1038/nnano.2011.153 · Cited by 347
Lund, A. W., Duraes, F. V., Hirosue, S., Raghavan, V. R., Nembrini, C., Thomas, S. N., Issa, A., Hugues, S., & Swartz, M. A. (2012) · Cell Reports · doi:10.1016/j.celrep.2012.01.005 · Cited by 341
Self-citationden Haan, J. M. M., & Bevan, M. J. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20020295 · Cited by 326
Moon, J. J., Suh, H., Li, A. V., Ockenhouse, C. F., Yadava, A., & Irvine, D. J. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1112648109 · Cited by 312
Self-citationReversal of Autoimmunity by Boosting Memory-like Autoregulatory T Cells
Tsai, S., Shameli, A., Yamanouchi, J., Clemente-Casares, X., Wang, J., Serra, P., Yang, Y., Medarova, Z., Moore, A., & Santamaria, P. (2010) · Immunity · doi:10.1016/j.immuni.2010.03.015 · Cited by 309
Hu, Y., Litwin, T., Nagaraja, A. R., Kwong, B., Katz, J., Watson, N., & Irvine, D. J. (2007) · Nano Letters · doi:10.1021/nl071542i · Cited by 305
Self-citationYeste, A., Nadeau, M., Burns, E. J., Weiner, H. L., & Quintana, F. J. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1120611109 · Cited by 302
Reis e Sousa, C., & Germain, R. N. (1995) · The Journal of experimental medicine · doi:10.1084/jem.182.3.841 · Cited by 296
PRINT: A Novel Platform Toward Shape and Size Specific Nanoparticle Theranostics
Perry, J. L., Herlihy, K. P., Napier, M. E., & DeSimone, J. M. (2011) · Accounts of Chemical Research · doi:10.1021/ar2000315 · Cited by 290
Inflammasome-activating nanoparticles as modular systems for optimizing vaccine efficacy
Demento, S. L., Eisenbarth, S. C., Foellmer, H. G., Platt, C., Caplan, M. J., Mark Saltzman, W., Mellman, I., Ledizet, M., Fikrig, E., Flavell, R. A., et al. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.03.034 · Cited by 290
Segura, E., Durand, M., & Amigorena, S. (2013) · Journal of Experimental Medicine · doi:10.1084/jem.20121103 · Cited by 288
In Vitro and in Vivo mRNA Delivery Using Lipid-Enveloped pH-Responsive Polymer Nanoparticles
Su, X., Fricke, J., Kavanagh, D. G., & Irvine, D. J. (2011) · Molecular Pharmaceutics · doi:10.1021/mp100390w · Cited by 287
Self-citationAntibody‐mediated modulation of immune responses
Nimmerjahn, F., & Ravetch, J. V. (2010) · Immunological Reviews · doi:10.1111/j.1600-065x.2010.00910.x · Cited by 285
Polymer multilayer tattooing for enhanced DNA vaccination
DeMuth, P. C., Min, Y., Huang, B., Kramer, J. A., Miller, A. D., Barouch, D. H., Hammond, P. T., & Irvine, D. J. (2013) · Nature Materials · doi:10.1038/nmat3550 · Cited by 277
Self-citationNg, G., Sharma, K., Ward, S. M., Desrosiers, M. D., Stephens, L. A., Schoel, W. M., Li, T., Lowell, C. A., Ling, C.-C., Amrein, M. W., et al. (2008) · Immunity · doi:10.1016/j.immuni.2008.09.013 · Cited by 276
A 2020 vision for vaccines against HIV, tuberculosis and malaria
Rappuoli, R., & Aderem, A. (2011) · Nature · doi:10.1038/nature10124 · Cited by 273
Therapeutic cancer vaccines: Are we there yet?
Klebanoff, C. A., Acquavella, N., Yu, Z., & Restifo, N. P. (2011) · Immunological Reviews · doi:10.1111/j.1600-065x.2010.00979.x · Cited by 271
Protection Against Vaginal SIV Transmission with Microencapsulated Vaccine
Marx, P. A., Compans, R. W., Gettie, A., Staas, J. K., Gilley, R. M., Mulligan, M. J., Yamshchikov, G. V., Chen, D., & Eldridge, J. H. (1993) · Science · doi:10.1126/science.8493576 · Cited by 261
Jewell, C. M., Bustamante López, S. C., & Irvine, D. J. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1105200108 · Cited by 245
Self-citationAntigen depot is not required for alum adjuvanticity
Hutchison, S., Benson, R. A., Gibson, V. B., Pollock, A. H., Garside, P., & Brewer, J. M. (2012) · The FASEB Journal · doi:10.1096/fj.11-184556 · Cited by 244
Zaks, K., Jordan, M., Guth, A., Sellins, K., Kedl, R., Izzo, A., Bosio, C., & Dow, S. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.12.7335 · Cited by 242
Zaric, M., Lyubomska, O., Touzelet, O., Poux, C., Al-Zahrani, S., Fay, F., Wallace, L., Terhorst, D., Malissen, B., Henri, S., et al. (2013) · ACS Nano · doi:10.1021/nn304235j · Cited by 233
Hirosue, S., Kourtis, I. C., van der Vlies, A. J., Hubbell, J. A., & Swartz, M. A. (2010) · Vaccine · doi:10.1016/j.vaccine.2010.09.077 · Cited by 233
Self-citationEngineering Approaches to Immunotherapy
Swartz, M. A., Hirosue, S., & Hubbell, J. A. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3003763 · Cited by 224
Self-citationScott, E. A., Stano, A., Gillard, M., Maio-Liu, A. C., Swartz, M. A., & Hubbell, J. A. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2012.04.060 · Cited by 221
Self-citationFrom Allergen Genes to Allergy Vaccines
Valenta, R., Ferreira, F., Focke-Tejkl, M., Linhart, B., Niederberger, V., Swoboda, I., & Vrtala, S. (2010) · Annual Review of Immunology · doi:10.1146/annurev-immunol-030409-101218 · Cited by 216
Villa, C. H., Dao, T., Ahearn, I., Fehrenbacher, N., Casey, E., Rey, D. A., Korontsvit, T., Zakhaleva, V., Batt, C. A., Philips, M. R., et al. (2011) · ACS Nano · doi:10.1021/nn200182x · Cited by 205
Synthesis and Biological Response of Size-Specific, Monodisperse Drug–Silica Nanoconjugates
Tang, L., Fan, T. M., Borst, L. B., & Cheng, J. (2012) · ACS Nano · doi:10.1021/nn300149c · Cited by 203
Crow, J. M. (2012) · Nature · doi:10.1038/488s2a · Cited by 203
A single-step immunization by sustained antigen release
Preis, I., & Langer, R. S. (1979) · Journal of Immunological Methods · doi:10.1016/0022-1759(79)90341-7 · Cited by 193
Thomasin, C., Corradin, G., Men, Y., Merkle, H. P., & Gander, B. (1996) · Journal of Controlled Release · doi:10.1016/0168-3659(96)01363-6 · Cited by 188
Nanoparticle conjugation of antigen enhances cytotoxic T-cell responses in pulmonary vaccination
Nembrini, C., Stano, A., Dane, K. Y., Ballester, M., van der Vlies, A. J., Marsland, B. J., Swartz, M. A., & Hubbell, J. A. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1104264108 · Cited by 187
Self-citationZhu, Q., Egelston, C., Gagnon, S., Sui, Y., Belyakov, I. M., Klinman, D. M., & Berzofsky, J. A. (2010) · Journal of Clinical Investigation · doi:10.1172/jci39293 · Cited by 186
Zhu, Q., Talton, J., Zhang, G., Cunningham, T., Wang, Z., Waters, R. C., Kirk, J., Eppler, B., Klinman, D. M., Sui, Y., et al. (2012) · Nature Medicine · doi:10.1038/nm.2866 · Cited by 185
Antigen kinetics determines immune reactivity
Johansen, P., Storni, T., Rettig, L., Qiu, Z., Der-Sarkissian, A., Smith, K. A., Manolova, V., Lang, K. S., Senti, G., Müllhaupt, B., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0706296105 · Cited by 184
Targeted delivery of TLR ligands to human and mouse dendritic cells strongly enhances adjuvanticity
Tacken, P. J., Zeelenberg, I. S., Cruz, L. J., van Hout-Kuijer, M. A., van de Glind, G., Fokkink, R. G., Lambeck, A. J. A., & Figdor, C. G. (2011) · Blood · doi:10.1182/blood-2011-07-367615 · Cited by 173
Immunology and the elusive AIDS vaccine
Virgin, H. W., & Walker, B. D. (2010) · Nature · doi:10.1038/nature08898 · Cited by 171
The cell biology of cross‐presentation and the role of dendritic cell subsets
Lin, M., Zhan, Y., Villadangos, J. A., & Lew, A. M. (2008) · Immunology & Cell Biology · doi:10.1038/icb.2008.3 · Cited by 166
Autologous Morphogen Gradients by Subtle Interstitial Flow and Matrix Interactions
Fleury, M. E., Boardman, K. C., & Swartz, M. A. (2006) · Biophysical Journal · doi:10.1529/biophysj.105.080192 · Cited by 161
Self-citationNanopatch‐Targeted Skin Vaccination against West Nile Virus and Chikungunya Virus in Mice
Prow, T. W., Chen, X., Prow, N. A., Fernando, G. J. P., Tan, C. S. E., Raphael, A. P., Chang, D., Ruutu, M. P., Jenkins, D. W. K., Pyke, A., et al. (2010) · Small · doi:10.1002/smll.201000331 · Cited by 160
Rose, R. D., Zelikin, A. N., Johnston, A. P. R., Sexton, A. L., Chong, S., Cortez‐Jugo, C., Mulholland, W. J., Caruso, F., & Kent, S. J. (2008) · Advanced Materials · doi:10.1002/adma.200801826 · Cited by 154
Garaude, J., Kent, A., van Rooijen, N., & Blander, J. M. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3002868 · Cited by 147
Novel vaccine development strategies for inducing mucosal immunity
Fukuyama, Y., Tokuhara, D., Kataoka, K., Gilbert, R. S., McGhee, Yuki, Y., Kiyono, H., & Fujihashi, K. (2012) · Expert Review of Vaccines · doi:10.1586/erv.11.196 · Cited by 146
Petersen, L. K., Ramer‐Tait, A. E., Broderick, S., Kong, C.-S., Ulery, B. D., Rajan, K., Wannemuehler, M. J., & Narasimhan, B. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.05.063 · Cited by 138
The relevance of non-human primate and rodent malaria models for humans
Langhorne, J., Buffet, P. A., Galinski, M. R., Good, M. F., Harty, J. T., Leroy, D., Mota, M. M., Pasini, E. M., Rénia, L., Riley, E. M., et al. (2011) · Malaria Journal · doi:10.1186/1475-2875-10-23 · Cited by 135
Ballester, M., Nembrini, C., Dhar, N., de Titta, A., de Piano, C., Pasquier, M., Simeoni, E., van der Vlies, A. J., McKinney, J. D., Hubbell, J. A., et al. (2011) · Vaccine · doi:10.1016/j.vaccine.2011.07.039 · Cited by 130
Self-citationGeest, B. G. D., Willart, M. A. M., Hammad, H., Lambrecht, B. N., Pollard, C., Bogaert, P., Filette, M. D., Saelens, X., Vervaet, C., Remon, J. P., et al. (2012) · ACS Nano · doi:10.1021/nn205099c · Cited by 130
In vivo distribution of surface-modified PLGA nanoparticles following intravaginal delivery
Cu, Y., Booth, C. J., & Saltzman, W. M. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.06.036 · Cited by 129
Kourtis, I. C., Hirosue, S., de Titta, A., Kontos, S., Stegmann, T., Hubbell, J. A., & Swartz, M. A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0061646 · Cited by 129
Self-citationEngineering complement activation on polypropylene sulfide vaccine nanoparticles
Thomas, S. N., van der Vlies, A. J., O’Neil, C. P., Reddy, S. T., Yu, S. S., Giorgio, T. D., Swartz, M. A., & Hubbell, J. A. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2010.11.037 · Cited by 127
Self-citationEncapsulation of the immune potentiators MPL and RC529 in PLG microparticles enhances their potency
Kazzaz, J., Singh, M., Ugozzoli, M., Chesko, J., Soenawan, E., & O’Hagan, D. T. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2005.10.010 · Cited by 120
Foged, C., Hansen, J. U., & Agger, E. M. (2011) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2011.08.016 · Cited by 117
Lipid-derived nanoparticles for immunostimulatory RNA adjuvant delivery
Nguyen, D. N., Mahon, K. P., Chikh, G., Kim, P., Chung, H., Vicari, A. P., Love, K. T., Goldberg, M. S., Chen, S., Krieg, A. Μ., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1121423109 · Cited by 110
Robust IgG responses to nanograms of antigen using a biomimetic lipid-coated particle vaccine
Bershteyn, A., Hanson, M. C., Crespo, M. P., Moon, J. J., Li, A. V., Suh, H., & Irvine, D. J. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.07.029 · Cited by 109
Self-citationVaccines and the Future of Human Immunology
Germain, R. N. (2010) · Immunity · doi:10.1016/j.immuni.2010.09.014 · Cited by 106
The Use of Nonhuman Primate Models in HIV Vaccine Development
Morgan, C. A., Marthas, M. L., Miller, C. J., Duerr, A. C., Cheng‐Mayer, C., Desrosiers, R. C., Flores, J., Haigwood, N. L., Hu, S.-L., Johnson, R. P., et al. (2008) · PLoS Medicine · doi:10.1371/journal.pmed.0050173 · Cited by 101
Synthetic mast-cell granules as adjuvants to promote and polarize immunity in lymph nodes
John, A. L. S., Chan, C. Y., Staats, H. F., Leong, K. W., & Abraham, S. N. (2012) · Nature Materials · doi:10.1038/nmat3222 · Cited by 100
Microparticle surface modifications targeting dendritic cells for non-activating applications
Lewis, J. S., Zaveri, T. D., Crooks, C. P., & Keselowsky, B. G. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2012.06.049 · Cited by 98
Precision Intracellular Delivery Based on Optofluidic Polymersome Rupture
Vasdekis, A. E., Scott, E. A., O’Neil, C. P., Psaltis, D., & Hubbell, J. A. (2012) · ACS Nano · doi:10.1021/nn302122h · Cited by 94
Nordly, P., Rose, F., Christensen, D., Nielsen, H. M., Andersen, P. L., Agger, E. M., & Foged, C. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.11.021 · Cited by 93
Singh, A. K., Qin, H., Fernandez, I., Wei, J., Lin, J. X., Kwak, L. W., & Roy, K. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.06.008 · Cited by 87
Development of a nanoparticle-based influenza vaccine using the PRINT® technology
Galloway, A. L., Murphy, A., DeSimone, J. M., Di, J., Herrmann, J. P., Hunter, M. E., Kindig, J. P., Malinoski, F. J., Rumley, M. A., Stoltz, D. M., et al. (2012) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2012.11.001 · Cited by 87
Heffernan, M. J., Kasturi, S. P., Yang, S. C., Pulendran, B., & Murthy, N. (2008) · Biomaterials · doi:10.1016/j.biomaterials.2008.10.034 · Cited by 73
pH-Triggered Microparticles for Peptide Vaccination
Haining, W. N., Anderson, D. G., Little, S. R., von Berwelt-Baildon, M. S., Cardoso, A. A., Alves, P. M. S., Kosmatopoulos, K., Nadler, L. M., Langer, R., & Kohane, D. S. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.4.2578 · Cited by 70
Otten, G. R., Schaefer, M. E., Greer, C. E., Calderon-Cacia, M., Coit, D., Kazzaz, J., Medina-Selby, A., Selby, M., Singh, M., Ugozzoli, M., et al. (2003) · Journal of Virology · doi:10.1128/jvi.77.10.6087-6092.2003 · Cited by 61
A Decade of Vaccines: Integrating Immunology and Vaccinology for Rational Vaccine Design
D’Argenio, D. A., & Wilson, C. B. (2010) · Immunity · doi:10.1016/j.immuni.2010.10.011 · Cited by 58
Antigen Release Kinetics in the Phagosome Are Critical to Cross-Presentation Efficiency
Howland, S. W., & Wittrup, K. D. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.3.1576 · Cited by 55
Vaccination against self to prevent autoimmune disease: the type 1 diabetes model
Harrison, L. C. (2008) · Immunology and Cell Biology · doi:10.1038/sj.icb.7100151 · Cited by 52
The role of inflammasomes in the immunostimulatory effects of particulate vaccine adjuvants
Harris, J., Sharp, F. A., & Lavelle, E. C. (2010) · European Journal of Immunology · doi:10.1002/eji.200940172 · Cited by 49
Therapeutic vaccines in autoimmunity
Sela, M., & Mozes, E. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0404826101 · Cited by 47
Tsuji, K., Hamada, T., Uenaka, A., Wada, H., Sato, E., Isobe, M., Asagoe, K., Yamasaki, O., Shiku, H., Ritter, G., et al. (2008) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-008-0478-5 · Cited by 44
Linhart, B., & Valenta, R. (2012) · Current Opinion in Immunology · doi:10.1016/j.coi.2012.03.006 · Cited by 42
HPV and Therapeutic Vaccines: Where are We in 2010?
Ma, B., Xu, Y., Hung, C., & Wu, T. ‐. (2010) · Current Cancer Therapy Reviews · doi:10.2174/157339410791202583 · Cited by 39
Velluto, D., Thomas, S. N., Simeoni, E., Swartz, M. A., & Hubbell, J. A. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.08.079 · Cited by 36
Self-citationPowell, T., Tang, J. T., DeRome, M., Mitchell, R. A., Jacobs, A., Deng, Y., Palath, N., Cardenas, E., Boyd, J. G., & Nardin, E. H. (2013) · Vaccine · doi:10.1016/j.vaccine.2013.02.027 · Cited by 26
Immunomodulation for prion and prion-related diseases
Wısnıewskı, T., & Goñi, F. (2010) · Expert Review of Vaccines · doi:10.1586/erv.10.131 · Cited by 19
Cited by
Cancer nanomedicine: progress, challenges and opportunities
Shi, J., Kantoff, P. W., Wooster, R., & Farokhzad, O. C. (2017) · Nature Reviews Cancer · doi:10.1038/nrc.2016.108 · Cited by 5,873
Emerging Frontiers in Drug Delivery
Tibbitt, M. W., Dahlman, J. E., & Langer, R. (2016) · Journal of the American Chemical Society · doi:10.1021/jacs.5b09974 · Cited by 975
Advances in Biomaterials for Drug Delivery
Fenton, O. S., Olafson, K. N., Pillai, P. S., Mitchell, M. J., & Langer, R. (2018) · Advanced Materials · doi:10.1002/adma.201705328 · Cited by 855
Synthetic Nanoparticles for Vaccines and Immunotherapy
Irvine, D. J., Hanson, M. C., Rakhra, K., & Tokatlian, T. (2015) · Chemical Reviews · doi:10.1021/acs.chemrev.5b00109 · Cited by 763
Self-citationImproving cancer immunotherapy using nanomedicines: progress, opportunities and challenges
Martin, J. D., Cabral, H., Stylianopoulos, T., & Jain, R. K. (2020) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-019-0308-z · Cited by 682
Metadata
- Authors
- Irvine, D. J., Swartz, M. A., & Szeto, G. L.
- Venue
- Nature Materials
- Published
- 2013-10-23
- Volume
- 12
- Issue
- 11
- Pages
- 978-990
- ISSN
- 1476-1122 (ISSN-L)
- 1476-4660
- OpenAlex
- W1524841546
- Cited by
- 594
- References
- 126
- FWCI
- 19.82
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.